Sou Hu Cai Jing·2026-01-14 12:16Group 1 - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Zhejiang Sunflower Health Technology Co., Ltd. due to misleading statements in its restructuring proposal [2] - The Shanghai Stock Exchange (SSE) has suspended trading for certain investor accounts related to Guosheng Technology due to abnormal trading behaviors and significant stock price fluctuations [3] - Guosheng Technology's stock price has experienced a cumulative increase of 511.92% since October 31, 2025, raising concerns about market overheating and irrational speculation [4] Group 2 - Guosheng Technology reported a significant decline in revenue, with a 57.79% year-on-year decrease, and a net profit of -151 million yuan for the first three quarters of the previous year [4] - The company's latest price-to-book ratio is significantly higher than the industry average, indicating potential stock price bubble characteristics [4] - Guosheng Technology's controlling shareholder has a high proportion of pledged shares, which poses additional risks [4]